AFLAC INC FY 2025 10-K, explained in plain English

Key financials — as reported

Total revenue	$17.2B
Gross margin	— not reported
Operating income	— not reported
Net income	$3.6B
Diluted EPS	$6.82
Cash & equivalents	$6.2B
Total assets	$116.5B
Long-term debt	— not reported

Key takeaway

Aflac Japan remains the company's principal earnings driver and the largest cancer/medical insurer in Japan, launching new products (Miraito cancer insurance, Anshin Palette medical insurance) in 2025.

🔒 4 more takeaways in the full analysis

Beneath the surface

Net debt is modest: total debt and capital lease obligations of $8.41 billion versus $6.25 billion cash suggests a manageable net debt position of roughly $2.16 billion for a company with $116 billion in assets, though most liquidity is tied up in longer-dated investments rather than pure cash.

🔒 3 more insights a headline reader would miss